GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Degree of Financial Leverage

Synthetic MR AB (XSAT:SYNT) Degree of Financial Leverage : 1.09 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Degree of Financial Leverage?

Degree of Financial Leverage (DFL) measures the percentage change in EPS for a unit change in Earnings Before Interest and Taxes (EBIT). Synthetic MR AB's Degree of Financial Leverage for the quarter that ended in Mar. 2024 was 1.09. The higher Degree of Financial Leverage, the more volatile earnings will be.

The industry rank for Synthetic MR AB's Degree of Financial Leverage or its related term are showing as below:

XSAT:SYNT's Degree of Financial Leverage is ranked better than
62.95% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 1.03 vs XSAT:SYNT: 1.09

Synthetic MR AB Degree of Financial Leverage Historical Data

The historical data trend for Synthetic MR AB's Degree of Financial Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Degree of Financial Leverage Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Degree of Financial Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 1.15 3.51 0.83 0.77

Synthetic MR AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Degree of Financial Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.40 1.47 1.42 0.77 1.09

Competitive Comparison of Synthetic MR AB's Degree of Financial Leverage

For the Health Information Services subindustry, Synthetic MR AB's Degree of Financial Leverage, along with its competitors' market caps and Degree of Financial Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's Degree of Financial Leverage Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Degree of Financial Leverage distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Degree of Financial Leverage falls into.



Synthetic MR AB Degree of Financial Leverage Calculation

Synthetic MR AB's Degree of Financial Leverage for the quarter that ended in Mar. 2024 is calculated as:

Degree of Financial Leverage=% Change in Earnings per Share (Diluted)**/% Change in EBIT
=( 0.37 (Mar. 2024) / 0.19 (Mar. 2023) - 1 )/( 17.842 (Mar. 2024) / 9.562 (Mar. 2023) - 1 )
=0.9474/0.8659
=1.09***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EPS and EBIT was used to calculate Degree of Financial Leverage.
*** Please be aware that the Degree of Financial Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Synthetic MR AB  (XSAT:SYNT) Degree of Financial Leverage Explanation

Degree of Financial Leverage (DFL) is a leverage ratio that measures the sensitivity of a company’s Earnings per Share (EPS) to fluctuations in its operating income, also referred to as Earnings Before Interest and Taxes (EBIT), resulting from adjustments in its capital structure. DFL is an essential tool for companies to assess the appropriate level of debt or financial leverage in their capital structure. When EBIT remains relatively stable, it results in stable earnings and earnings per share. In such cases, the company may consider taking on substantial debt. However, for companies operating in industries with significant fluctuations in EBIT, it is advisable to keep debt at a manageable level.

The higher Degree of Financial Leverage, the more volatile earnings will be. Because interest is a fixed expense, leverage can amplify earnings and EPS. This is beneficial when EBIT is growing, but it can become problematic in tough economic conditions when EBIT is under pressure.

Be Aware

The use of financial leverage varies across different industries and business sectors, and the application of Degree of Financial Leverage (DFL) should be adjusted accordingly.


Synthetic MR AB Degree of Financial Leverage Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Degree of Financial Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Syntel Inc. Reports Operating Results (10-K)

By gurufocus 10qk 03-03-2011

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018

Syntel to Present at Investor Conference

By Marketwired Marketwired 05-29-2018

Syntel Inc.: Value at a Value Price

By MV Research maziume 01-03-2017

Interim CEO Invests in IT Company

By Jennifer Chiou Jennifer Chiou 12-07-2016

Syntel to Present at Investor Conference

By Marketwired Marketwired 05-10-2018

Insiders Are Investing in Syntel

By Kyle Ferguson Kyle Ferguson 04-27-2017

Third Avenue Management Comments on Syntel

By Holly LaFon 07-02-2013